» Articles » PMID: 23507788

Impact of Right Ventricular Reserve on Exercise Capacity and Survival in Patients with Pulmonary Hypertension

Overview
Publisher Wiley
Date 2013 Mar 20
PMID 23507788
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Pulmonary hypertension is a clinical syndrome characterized by a progressive increase in pulmonary vascular resistance leading to right ventricular failure and death. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are key subgroups of this disorder with comparable clinical and pathological findings. Resting pulmonary haemodynamics correlate only moderately with functional parameters and do not predict prognosis in these patients sufficiently accurately. We therefore correlated exercise haemodynamics with peak oxygen uptake (peakVO2) and determined their prognostic significance.

Methods And Results: Thirty-six consecutive patients (21 female, 54 ± 15 years) with PAH (n = 21) or inoperable CTEPH were studied. The mean follow-up period was 1709 ± 837 days. All patients underwent right heart catheterization at rest and during exercise, and cardiopulmonary exercise testing. Patients had severe pulmonary hypertension at rest (mean pulmonary artery pressure 46 + 11 mmHg, cardiac index 2.2 ± 0.6 L/min/m(2), pulmonary vascular resistance 861 ± 330 dynes/s/cm(5)). Exercise cardiac index correlated with peakVO2 (r = 0.59, P < 0.001) and was the only independent predictor of peakVO2 on multivariate stepwise linear regression analyses (P < 0.001). PeakVO2 was the strongest predictor of survival (χ(2) = 14.5, P = 0.003). Among haemodynamic variables, only exercise cardiac index (χ(2) = 5.6, P = 0.018) and the slope of the pressure/flow relationship (χ(2) = 4.1, P = 0.04) were significant prognostic indicators.

Conclusion: The ability of the right ventricle to increase the cardiac index during exercise is an important determinant of exercise capacity in patients with pulmonary hypertension. It also predicts prognosis and might therefore be useful in the clinical assessment of these patients.

Citing Articles

Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.

Tarras E, Singh I, Kreiger J, Joseph P J Clin Med. 2025; 14(3).

PMID: 39941482 PMC: 11818252. DOI: 10.3390/jcm14030804.


Invasive Cardiopulmonary Exercise Testing in Chronic Thromboembolic Pulmonary Disease; Obesity and the V/VCO Relationship.

Oliveros E, Mauri M, Pietrowicz R, Sadek A, Lakhter V, Bashir R J Clin Med. 2025; 13(24.

PMID: 39768625 PMC: 11677292. DOI: 10.3390/jcm13247702.


Echocardiographic assessment for cardiopulmonary function in patients with congenital heart disease-related pulmonary arterial hypertension.

Yang L, Luo D, Huang T, Li X, Zhang G, Zhang C BMC Pulm Med. 2024; 24(1):306.

PMID: 38944669 PMC: 11214696. DOI: 10.1186/s12890-024-03113-7.


Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function.

Ichimura K, Gross A, Mathew R, Salman L, Reddy S, Spiekerkoetter E Cardiovasc Drugs Ther. 2024; .

PMID: 38847906 DOI: 10.1007/s10557-024-07588-8.


Poor cardiac output reserve in pulmonary arterial hypertension is associated with right ventricular stiffness and impaired interventricular dependence.

Cubero Salazar I, Lancaster A, Jani V, Montovano M, Kauffman M, Weller A Eur Respir J. 2024; 64(1).

PMID: 38843915 PMC: 11836945. DOI: 10.1183/13993003.00420-2024.